Bitrobius Genetics: Scaling revolutionary gene therapy at Alderley Park
By Bruntwood SciTech
Gene therapy innovator Bitrobius Genetics, transformed a spare-room concept into a life-saving clinical reality. To do so they required more than just venture capital - it demanded an immersive, highly supportive scientific ecosystem.
By launching their operations within the Open Access Lab at Alderley Park, they gained immediate, crucial access to shared technological equipment, drastically accelerating their pioneering research.
Discover how we empower ambitious health tech founders with highly adaptable, premium lab spaces that seamlessly scale alongside explosive business growth. Operating under one roof with other industry-leading institutions has fostered the deep collaboration necessary to cure complex genetic diseases.
Discover more about their revolutionary DNA delivery technologies at https://bitrobius.com, or explore our flexible life science facilities at Alderley Park.
Bitrobius Genetics is a gene therapy company. We develop new technologies for delivering DNA into cells, and that DNA carries a correct copy of a faulty gene. So the idea is that you can put it into a certain organ and replace the gene that's causing the disease. We're developing a new technology called Gentroix, which will allow us to develop cures for a number of different genetic diseases.
It really started off as just a concept in my spare room. I got venture capital funding to start the company up, and then that allowed us to move into Alderley Park and set up operations here.
There are a number of excellent services at Alderley Park; they've really supported our research. One of those is the Open Access Lab, which is where we first started, and that was really useful because it's provided a number of different shared equipment which we didn't have at the time. Being a brand new startup, we could get going much quicker.
It has labs of all different sizes, so we can grow as we expand into the space we need, and also had the facilities and the other companies located here—institutions that we could collaborate with. So everything that we needed was under one roof.